Date published: 2026-6-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

T-FABP Antibody (AT13F9): sc-517426

0.0(0)
Write a reviewAsk a question

Datasheets
  • T-FABP Antibody (AT13F9) is a mouse monoclonal IgG1 κ provided at 100 µg/ml
  • raised against a recombinant protein corresponding to amino acids 1-132 of T-FABP of human origin
  • recommended for detection of T-FABP of human origin by WB and ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for T-FABP Antibody (AT13F9). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    T-FABP Antibody (AT13F9) is a mouse monoclonal IgG1 antibody that detects T-FABP in human samples through applications such as western blotting (WB) and enzyme-linked immunosorbent assay (ELISA). T-FABP, also known as PERF, FABP9, or PERF15, is a member of the fatty acid-binding protein family and is specifically expressed in testicular germ cells during spermatogenesis, playing a crucial role in germ cell development. T-FABP (AT13F9) antibody enables detection of T-FABP in the testis, suggesting a specialized function in the transport and metabolism of fatty acids, which are vital for the energy needs and membrane synthesis of developing sperm cells. By facilitating the uptake and intracellular transport of fatty acids, T-FABP contributes to the overall lipid homeostasis necessary for proper spermatogenesis, highlighting its significance in male fertility. Anti-T-FABP antibody (AT13F9) serves as an essential tool for researchers investigating the mechanisms of spermatogenesis and the role of fatty acid metabolism in reproductive health.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    T-FABP Antibody (AT13F9) References:

    1. Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers.  |  Pritt, ML., et al. 2008. Toxicol Sci. 103: 382-96. PMID: 18308699
    2. Silencing of FABP3 promotes apoptosis and induces mitochondrion impairment in embryonic carcinoma cells.  |  Shen, YH., et al. 2012. J Bioenerg Biomembr. 44: 317-23. PMID: 22528395
    3. Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells.  |  Song, GX., et al. 2012. J Cell Biochem. 113: 3701-8. PMID: 22753283
    4. Silencing of FABP3 inhibits proliferation and promotes apoptosis in embryonic carcinoma cells.  |  Shen, Y., et al. 2013. Cell Biochem Biophys. 66: 139-46. PMID: 23097025
    5. Preservation of cochlear function in Fabp3 (H-Fabp) knockout mice.  |  Suzuki, J., et al. 2014. Neurosci Res. 81-82: 64-8. PMID: 24560810
    6. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.  |  Jung, TW., et al. 2018. Exp Mol Med. 50: 1-11. PMID: 30213948
    7. [Effect of silencing FABP3 gene on LPS-induced apoptosis and endoplasmic reticulum stress in alveolar epithelial cells].  |  Wu, X., et al. 2019. Zhonghua Yi Xue Za Zhi. 99: 3808-3813. PMID: 31874519
    8. Crucial Role of FABP3 in αSyn-Induced Reduction of Septal GABAergic Neurons and Cognitive Decline in Mice.  |  Matsuo, K., et al. 2021. Int J Mol Sci. 22: PMID: 33401521
    9. miR-381-3p Inhibits Intramuscular Fat Deposition through Targeting FABP3 by ceRNA Regulatory Network.  |  Jiang, Y., et al. 2022. Biology (Basel). 11: PMID: 36290402
    10. A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer's disease patients from controls.  |  Pesämaa, I., et al. 2023. Mol Neurodegener. 18: 70. PMID: 37775827

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    T-FABP Antibody (AT13F9)

    sc-517426
    100 µg/ml
    $322.00